Literature DB >> 18787049

Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident.

Angela Cecilia Pesatori1, Andrea Baccarelli, Dario Consonni, Andrea Lania, Paolo Beck-Peccoz, Pier Alberto Bertazzi, Anna Spada.   

Abstract

OBJECTIVE: The pathogenesis of sporadic pituitary tumors is unknown. Loss-of-function mutations of aryl hydrocarbon receptor-interacting protein (AIP) have been identified in patients with familial pituitary tumors. AIP is a chaperone protein with multifunction properties, including modulation of the transcriptional activity of the aryl hydrocarbon receptor, which mediates toxicological and carcinogenic dioxin effects.
DESIGN: We investigated the incidence of pituitary tumors in the Seveso population exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin following an industrial accident in 1976.
METHODS: Through the hospital discharge registration system of Lombardy Region, we identified incident cases of pituitary adenomas between 1976 and 1996 in the Seveso population, subdivided in zone A (n=804), B (n=5.941), and R (n=38.624) according to high, intermediate, and low exposure to dioxin respectively, and in the surrounding non-contaminated area, as reference (n=232 745).
RESULTS: We identified 42 pituitary adenomas in the reference area, 1 prolactinoma in zone A (rate ratio (RR) 6.2; 95% CI 0.9-45.5, P=0.07), 2 nonfuctioning pituitary tumors (NFPAs) in zone B (RR 1.9; 95% CI 0.5-7.7, P=0.39), and 3 prolactinomas and 2 NFPAs in zone R (RR 0.7; 95% CI 0.3-1.8, P=0.48).
CONCLUSIONS: The study is unique with regard to the availability of epidemiological and clinical data in an area of relatively pure dioxin exposure. The study indicates no statistically significant increase of incident pituitary tumors in this area, although the tendency toward a higher risk (three cases in zones A and B) of pituitary tumors in subjects exposed to high-intermediate dioxin concentrations in comparison with nonexposed population suggests the need for extended follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787049     DOI: 10.1530/EJE-08-0593

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

Review 1.  The Complex Biology of the Aryl Hydrocarbon Receptor and Its Role in the Pituitary Gland.

Authors:  Robert Formosa; Josanne Vassallo
Journal:  Horm Cancer       Date:  2017-06-20       Impact factor: 3.869

Review 2.  Environmental epigenetics.

Authors:  V Bollati; A Baccarelli
Journal:  Heredity (Edinb)       Date:  2010-02-24       Impact factor: 3.821

Review 3.  Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Authors:  Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

4.  A history of pituitary pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

Review 5.  Epidemiology and etiopathogenesis of pituitary adenomas.

Authors:  Elena D Aflorei; Márta Korbonits
Journal:  J Neurooncol       Date:  2014-01-31       Impact factor: 4.130

Review 6.  The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.

Authors:  Catrin Lloyd; Ashley Grossman
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

Review 7.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

8.  Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas.

Authors:  S Cannavo; F Ferrau; O R Cotta; S Saitta; V Barresi; M T Cristani; A Saija; R M Ruggeri; F Trimarchi; S Gangemi
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

Review 9.  Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification.

Authors:  Ashley B Grossman; Shereen Ezzat; Sylvia L Asa; Ozgur Mete; Michael D Cusimano; Ian E McCutcheon; Arie Perry; Shozo Yamada; Hiroshi Nishioka; Olivera Casar-Borota; Silvia Uccella; Stefano La Rosa
Journal:  Mod Pathol       Date:  2021-05-21       Impact factor: 7.842

10.  Benzene and 2-ethyl-phthalate induce proliferation in normal rat pituitary cells.

Authors:  Laura Tapella; Antonella Sesta; Maria Francesca Cassarino; Valentina Zunino; Maria Graziella Catalano; Francesca Pecori Giraldi
Journal:  Pituitary       Date:  2017-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.